Liver Cancer

Immunotherapy Combo Reduces Risk of Cancer Recurrence in Early-Stage Liver Cancer

By

Brian Park, PharmD

Publish Date January 26, 2023

The IMbrave050 study included 662 patients with HCC at high risk for recurrence after surgical resection or ablation with curative intent.

Radiation Dose and Inflammation Contribute to Post-SBRT Liver Dysfunction in HCC

By

Jessica Nye, PhD

Publish Date November 9, 2022

Researchers sought to determine the relationship between direct radiation dose and inflammation and regional hepatic function after stereotactic body radiation therapy for hepatocellular carcinoma.

Liver Cancer in Top Five Causes of Cancer Deaths in 90 Countries

Publish Date October 20, 2022

The number of people diagnosed with liver cancer is predicted to rise substantially by 2040.

Imfinzi Plus Chemotherapy Approved for Advanced Biliary Tract Cancer

By

Diana Ernst, RPh

Publish Date September 15, 2022

The approval was based on data from the phase 3 TOPAZ-1 trial.

Increasing BMI Tied to Higher Risk of Liver and Biliary Tract Cancers

By

Andrea S. Blevins Primeau, PhD, MBA

Publish Date September 12, 2022

Individuals who are overweight or obese, or who become overweight or obese over time, have a higher risk of liver cancer and biliary tract cancer.

Liver Cancer Clinical Trials

NSCLC: Study Assesses Adjuvant Chemo Decision-making Role Preferences

Clinical Trial: Bevacizumab and Erlotinib or Sorafenib as First-Line Therapy in Treating Patients With Advanced Liver Cancer

Clinical Trials: Chemoembolization Versus Radioembolization in Treating Patients With Liver Cancer That Cannot Be Treated With Radiofrequency Ablation Or Surgery

Clinical Trial: Transarterial Chemoembolization With Doxorubicin With or Without Everolimus in Treating Patients With Liver Cancer

Clinical Trial: Fusion Guided Thermal Ablation Combined With External Beam Radiation for Hepatic Neoplasms.